Status:
COMPLETED
Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Prader-Willi Syndrome
Eligibility:
All Genders
3-2 years
Brief Summary
The PWS is a genetic disease with intellectual disabilities associated with multiple manifestations in other body systems. It is characterized by hypothalamic-pituitary abnormalities with severe hypot...
Eligibility Criteria
Inclusion
- Children under 2 years
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 29 2019
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02205450
Start Date
September 1 2014
End Date
July 29 2019
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporació Sanitària Parc Taulí
Sabadell, Barcelona, Spain, 08208